Asset
PERPHENAZINE 4-AMINOBUTYRATE
BioLineRx Ltd. American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00480246 | phase1 | completed | 2007-05-01 | — | BioLineRx, Ltd. | A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer |
| NCT00722176 | phase2 | completed | 2008-06-01 | 2009-07-01 | BioLineRx, Ltd. | Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 |
| NCT00480571 | phase2 | completed | 2007-06-01 | 2007-12-01 | BioLineRx, Ltd. | Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder |
FDA applications (0)
This company has no applications containing this asset.